THE MD-224 DIARIES

Proteolysis-concentrating on chimeras (PROTACs) and molecular glue degraders (MGDs) are the most maturely created TPD strategies. On this assessment, we concentrate on the two preclinical experiments and medical trials to supply an extensive summary of the protection and medical usefulness of PROTACs and MGDs in hematologic malignancies over the pa